Estrogen Replacement
Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy
... endogenous estrogen depletion and a potential role of exogenous estrogen replacement ...Exogenous estrogen replace- ment therapy resulted in complete rescue of cardiopul- monary hemodynamics ...
10
Comparing the Effects of Various Estrogen Replacement Paradigms on Working Memory Performance in the Radial-Arm Maze
... with estrogen status to affect radial-arm maze ...that estrogen replacement enhances working memory performance in animals reared in isolated environments, not this effect of estrogen was not ...
42
The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women
... of estrogen replacement therapy has a major impact on the growth hormone (GH)/insulin-like growth factor-I (IGF-I) ...axis. Estrogen administration by the oral, but not the transdermal route, reduces ...
7
Optimizing Estrogen Replacement Treatment in Turner Syndrome
... ABSTRACT. Estrogen has a biphasic effect on growth, stimulatory at low doses but inhibitory at higher ...hormone replacement treatment in girls with Turner syndrome (TS) who are being treated with growth ...
5
Effects of delayed estrogen treatment and 20 HETE synthesis inhibition on postischemic pial artery response to acetylcholine in rats
... of estrogen on postischemic cerebral vasomotor dynamics after ischemic ...of estrogen on brain rescue once a cerebral ischemic event ...(OV), estrogen-treated OVX females (E1; estrogen started ...
10
PROSPECTS AND CONSEQUENCES OF HORMONE REPLACEMENT THERAPY IN CANCERS A REVIEW
... A meta-analysis of major breast cancer studies did not show an increased risk of breast cancer in women who had ever received estrogen replacement therapy compared with those who had not. Women can ...
5
Prospective, randomized, double blind, placebo controlled phase IIa clinical trial on the effects of an estrogen progestin combination as add on to inpatient psychotherapy in adult female patients suffering from anorexia nervosa
... The present trial is the first of its kind. Most trials have examined the effect of estrogen replacement upon bone mineral density in adolescent patients suffering from AN. Thus, in this phase IIa clinical ...
11
Protective effects of pomegranate seed oil on ovariectomized rats as a model of postmenopausal osteoporosis: A multi-detector computed tomography evaluation
... that estrogen replacement therapy can prevent the early phase of involutional bone loss and also restore the rate of bone resorption and formation to premenopausal levels in menopausal ...are ...
5
Hormone Replacement Therapy and Cardiovascular Disease.pdf
... F or more than 50 million American women, and millions of women in other countries who are over the age of 50 years, the decision whether or not to use estrogen replacement therapy (ERT) for chronic disease ...
6
17β-estradiol lowers triglycerides in adipocytes via estrogen receptor α and it may be attenuated by inflammation
... estradiol replacement therapy in postmen- opausal women was demonstrated to be efficient to at- tenuate the progress of atherosclerosis ...and Estrogen/progestin Replacement Study (HERS) and the ...
6
Two Long-Term Follow-Up Cases Preventing Atherosclerosis by Hormone Replacement Therapy-CETP Deficiency and Tangier Disease
... During her first visit in October 2005, T. cholesterol 82 mg/dL, HDL-C 2 mg/dl, triglyceride 144 mg/dL, and estimated LDL-C 52 mg/dl were obtained. LDL-C/HDL-C was 25.5. ANA 40 with discrete speckle and platelet 8.9x104 ...
5
A Review of Pharmacotherapy and Treatment in Osteoporosis
... with estrogen replacement therapy to prevent fracture has been ...on estrogen replacement therapy was the first large-scale, randomized, controlled study of healthy women aged 50–79 ...using ...
5
Antiaging therapy: A boom in sustaining human quest for youth
... So far, caloric restriction has the soundest basis and estrogen replacement is among the interventions most commonly used http:// www.antiagingny.com; accessed 9 Sept.. Indian Journal of[r] ...
6
Battle of the sex steroids in the male skeleton: and the winner is…
... both estrogen and testosterone defi- cient, though sex steroids were measured by a less sensitive and specific method (radioimmunoassay) than that used by Finkelstein et ...of estrogen defi- ciency on bone ...
5
Prospective and retrospective study of weekly intermittent hormone (estrogen and progesterone) replacement therapy in hysterectomised women
... To nullify risk of endometrial hyperplasia and subsequent carcinoma we selected only hysterectomised women. These tablets are available free of cost in our institute hospital with brand name of MALA-D which contains ...
6
17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression
... by estrogen, anti-estrogen treatment is commonly used in breast ...hormone replacement therapy (HRT) for 5 years, and higher lung cancer incidence and mortality rate were found in the HRT group ...as ...
18
You say estren, I say estrogen Let’s call the whole replacement off!
... reproductive organs. In 2002, the synthetic ligand estren was described to reproduce the bone anabolic, nongenotropic effects of sex steroids while having no effect on the uterus or seminal vesicles. But in the current ...
5
Prediagnostic use of hormone therapy and mortality after breast cancer.
... In an earlier study, Bergkvist et al compared a group of 261 cases of breast cancer that had taken E-only prior to diagnosis with 6627 breast cancer cases identified through a population cancer registry whose ...
26
Current treatment options for postmenopausal vaginal atrophy
... of estrogen deficiency can be carried out with hormonal preparations with systemic and local action, as well as with preparations of plant ...pharmacological estrogen preparations sufficiently and quickly ...
9
Hormone therapy and ovarian cancer: incidence and survival.
... cohort study, Lacey et al. detected a significantly increased risk of ovarian cancer in women who had used estrogen therapy for 10-19 years (HR=1.8, 95% CI: 1.1-3.0) or more than 20 years (HR=3.2, 95% CI: 1.7-5.7) ...
23